Great news, solid data! Looking like a near term expansion in the addressable market for EPP (with younger patients in greater need of a treatment like Scenesse)!
Hopefully soon preliminary or interim data for Vitiligo as well (AAD perhaps?)
Ann: Preliminary results from SCENESSE adolescent EPP study, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.89 |
Change
-0.110(0.92%) |
Mkt cap ! $595.9M | |||
| Open | High | Low | Value | Volume |
| $11.75 | $12.24 | $11.68 | $1.039M | 86.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 177 | $11.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 3 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |